Almost two years with COVID-19: some aspects of antibiotic use-Reference-Cited by-同舟云学术

Almost two years with COVID-19: some aspects of antibiotic use

Published:2021 Issue:3 Volume:23 Page:248-253
ISSN:2686-9586
Container-title:Clinical Microbiology and Antimicrobial Chemotherapy
language:ru
Short-container-title:CMAC

Author:

Ortenberg Eduard A.¹^ORCID

Affiliation:

1. Tyumen State Medical University (Tyumen, Russia)

Abstract

The objective of this review was to summarize impact of the widespread administration of antibiotics in treatment algorithms for patients with COVID-19 on treatment outcomes. The experience of antimicrobial use agents during COVID-19 pandemic did not show any life-saving effect. It justifies a need to limit their administration to COVID-19 patients.

Publisher

Interregional Association for Clinical Microbiology and Antimicrobial Chemotherapy

Subject

Pharmacology (medical),Infectious Diseases,Microbiology (medical),Epidemiology

Reference45 articles.

1. Ginsburg A.S., Klugman K.P. COVID-19 pneumonia and the appropriate use of antibiotics. Lancet Glob Health. 2020;8(12):e1453-e1454. DOI: 10.1016/S2214-109X(20)30444-7

2. Mahoney A.R., Safaee M.M., William M., Wuest W.M., Furst A. The silent pandemic: emergent antibiotic resistances following the global response to SARS-CoV-2. iScience. 2021;102304. DOI: 10.1016/j.isci.2021.102304

3. Interim methodological recommendations. Prevention, diagnostics and treatment of new coronavirus infection (COVID-19). Available at: https://static-0.minzdrav.gov.ru/system/attachments/attaches/000/054/588/original/%D0%92%D1%80%D0%B5%D0%BC%D0%B5%D0%BD%D0%BD%D1%8B%D0%B5_%D0%9C%D0%A0_COVID19_%28v.10%29-08.02.2021_%281%29.pdf Russian.

4. Drożdżal S., Rosik J., Lechowicz K., Machaj F., Kotfis K., Ghavamiet S., et al. FDA approved drugs with pharmacotherapeutic potential for SARS-CoV-2 (COVID-19) therapy. Drug Resist Updat. 2020;53:100719. DOI: 10.1016/j.drup.2020.100719

5. Trivedi N., Verma A., Kumar D. Possible treatment and strategies for COVID-19: review and assessment. Eur Rev Med Pharmacol Sci. 2020;24(23):12593-12608. DOI: 10.26355/eurrev_202012_24057

Cited by 2 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Microbial associations for pneumonia causative agents and level of their resistance to antimicrobial drugs during a new coronavirus infection pandemic;Russian Journal of Infection and Immunity;2024-02-02

2. Comparative Analysis of Bacterial Microflora Isolated from Adult Pneumonia Inpatients and Hospital Objects in the Amur Region;ЗДОРОВЬЕ НАСЕЛЕНИЯ И СРЕДА ОБИТАНИЯ - ЗНиСО / PUBLIC HEALTH AND LIFE ENVIRONMENT;2022-07